- ISIN
- US46435U1925
- CUSIP
- 46435U192
- Issuer
- iShares
- Inception Date
- Jun 11, 2019
- Region
- North America (U.S.)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- NYSE FactSet Global Genomics and Immuno Biopharma Index
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Multi-Cap
- Asset Class Style
- Blend
- Assets Under Management
- $196M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IDNA Performance Chart
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) is up 26.3% since the beginning of the year. IDNA is currently trading at $33 per share. Investors who bought $1,000 worth of IDNA shares 5 years ago would now be looking at an investment worth $718.
Loading charts...
Returns By Period
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has returned 26.34% so far this year and 57.08% over the past 12 months.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
- 1D
- -1.79%
- 1M
- 11.15%
- 6M
- 19.72%
- YTD
- 26.34%
- 1Y
- 57.08%
- 3Y*
- 12.75%
- 5Y*
- -6.42%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.79%
- 1M
- 1.13%
- 6M
- 7.71%
- YTD
- 9.79%
- 1Y
- 20.06%
- 3Y*
- 18.60%
- 5Y*
- 11.43%
- 10Y*
- 13.27%
IDNA Monthly Returns History
Based on dividend-adjusted daily data since Jun 13, 2019, IDNA's average daily return is +0.04%, while the average monthly return is +0.67%. At this rate, an investment would double in approximately 8.7 years.
Historically, 52% of months were positive and 48% were negative. The best month was Nov 2020 with a return of +17.9%, while the worst month was Jan 2022 at -17.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.
On a daily basis, IDNA closed higher 51% of trading days. The best single day was Jun 17, 2019 with a return of +7.7%, while the worst single day was Mar 12, 2020 at -10.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.86% | 9.19% | -6.68% | 1.17% | 1.67% | 13.43% | -2.37% | 26.34% | |||||
| 2025 | 0.75% | -1.32% | -8.93% | 2.59% | -3.76% | 2.12% | 3.61% | 4.27% | 6.58% | 7.37% | 8.66% | -4.38% | 17.26% |
| 2024 | -3.13% | 8.61% | -0.54% | -6.19% | 4.96% | -2.04% | 7.27% | 0.65% | -1.39% | -1.97% | 2.45% | -8.02% | -0.72% |
| 2023 | 7.03% | -10.62% | -3.36% | 0.73% | 1.71% | -1.76% | 2.68% | -6.18% | -9.55% | -10.96% | 13.85% | 12.37% | -7.63% |
| 2022 | -17.12% | -4.21% | -0.95% | -13.64% | -3.63% | 1.28% | 9.55% | -6.26% | -11.08% | 3.26% | 3.27% | -10.55% | -42.28% |
| 2021 | 9.60% | -6.63% | -2.77% | 4.90% | -2.34% | 11.22% | -3.69% | 7.50% | -5.87% | -2.01% | -4.53% | -7.12% | -3.98% |
Benchmark Metrics
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund has an annualized alpha of -4.78%, beta of 0.91, and R2 of 0.38 versus S&P 500 Index. Calculated based on daily prices since June 13, 2019.
- This ETF participated in 112.63% of S&P 500 Index downside but only 77.32% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.38 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -4.78%
- Beta
- 0.91
- R²
- 0.38
- Upside Capture
- 77.32%
- Downside Capture
- 112.63%
Expense Ratio
IDNA has an expense ratio of 0.47%, placing it in the medium range.
Return for Risk
Risk / Return Rank
IDNA ranks 87 for risk / return — in the top 87% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDNA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.67 | ||
| Sortino ratioReturn per unit of downside risk | +0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.29 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 5.38 | 2.21 | +3.16 |
| Martin ratioReturn relative to average drawdown | 14.96 | 9.61 | +5.35 |
Dividends
Dividend History
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund provided a 0.85% dividend yield over the last twelve months, with an annual payout of $0.28 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $0.28 | $0.31 | $0.22 | $0.24 | $0.14 | $0.31 | $0.12 | $0.24 |
Dividend yield | 0.85% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.13 | $0.00 | $0.13 | |||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.31 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.22 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.24 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 | $0.31 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund was 68.26%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund drawdown is 37.71%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -68.26%Oct 2023 | 2y 1mo | — | 4y 10moSep 2021 - now |
COVID crash2020 | -26.93%Mar 2020 | 11d | 1mo 2d | 1mo 13dMar 2020 - Apr 2020 |
2021 bear market2021 | -22.23%Mar 2021 | 27d | 5mo 4d | 6mo 1dFeb 2021 - Aug 2021 |
2019 correction2019 | -14.38%Oct 2019 | 2mo 22d | 1mo 12d | 4mo 4dJul 2019 - Nov 2019 |
2020 correction2020 | -13.58%Sep 2020 | 1mo 19d | 1mo 1d | 2mo 20dJul 2020 - Oct 2020 |
Drawdown Indicators
| IDNA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -56.78% | -11.48% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -9.10% | -1.56% |
Max Drawdown (3Y)Largest decline over 3 years | -29.46% | -18.90% | -10.56% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | -25.43% | -42.83% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -37.71% | -1.24% | -36.47% |
Average DrawdownAverage peak-to-trough decline | -36.28% | -10.71% | -25.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.83% | 2.09% | +1.74% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with IDNA
Add iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IDNA